R&D

Research and Development

Research Achievements

  • Development of the technologies for the modulation of xenogeneic immune responses using four non-peptide antigen deficient pigs
    Research Period 2020. 06. 01 ~ 2022. 12. 31
    Research Institute Expected Effects
    Research InstituteNational Research Foundation of Korea Expected EffectsDevelopment of the technologies for the modulation of xenogeneic immune responses using four non-peptide antigen deficient pigs
  • Development of GMP grade tissue dissociation enzyme for the manufacturing of innovative biotherapeutics to treat chronic diseases
    Research Period 2020. 06. 01 ~ 2022. 12. 31
    Research Institute Expected Effects
    Research InstituteKorea Evaluation Institute of Industrial Technology Expected EffectsDevelopment of GMP grade tissue dissociation enzyme
  • Discovery of nanoparticle platform based vaccine candidate substance expressing respiratory syncytial virus-F(RSV-F)
    Research Period 2021. 01. 01 ~ 2022. 12. 31
    Research Institute Expected Effects
    Research InstituteKorea Health Industry Development Institute Expected EffectsDeveloped own technology for prevent respiratory syncytial virus infections
  • Validation of clinical applicability throgh xenotransplantation with nonhuman primate from DPF/transgenic pigs
    Research Period 2020. 04. 23 ~ 2022. 12. 31
    Research Institute Expected Effects
    Research InstituteKorea Health Industry Development Institute Expected EffectsValidation of clinical applicability throgh xenotransplantation